Article
Surgery
Albert Alhatem, Patrick L. Quinn, Weiyi Xia, Ravi J. Chokshi
Summary: Through analyzing 39 cases of PCS, it was found that most PCS patients had either regionally invasive or metastatic disease, and an increase in tumor extension was significantly associated with decreased overall survival. Surgery was shown to improve overall survival, but its effect was less pronounced for metastatic disease; the adjusted analysis revealed that metastatic disease was the only significant predictor of survival.
JOURNAL OF SURGICAL RESEARCH
(2021)
Article
Radiology, Nuclear Medicine & Medical Imaging
Kumar Mukherjee, Neena Davisson, Sana Malik, Richard Duszak, Nima Kokabi
Summary: This study compared the utilization, outcomes, and costs of surgery, radiation therapy, and percutaneous ablation for stage I non-small cell lung cancer. The findings showed an increase in radiation therapy utilization, a decrease in surgery utilization, and consistently low utilization of percutaneous ablation. Although surgery had the best overall survival, percutaneous ablation had the lowest first year treatment costs.
ACADEMIC RADIOLOGY
(2022)
Article
Public, Environmental & Occupational Health
Jiang Zhong, XingShu Liao, Shuang Peng, Junyi Cao, Yue Liu, Chunyang Liu, Ju Qiu, Xiaoyan Guan, Yang Zhang, Xiaozhu Liu, Shengxian Peng
Summary: In this study, a web-based prediction model for overall survival in elderly patients with pancreatic cancer (PC) was constructed and validated. The model may be useful for prognostic assessment, treatment strategy selection, and follow-up management of these patients.
FRONTIERS IN PUBLIC HEALTH
(2022)
Article
Public, Environmental & Occupational Health
S. Namin, Y. Zhou, E. McGinley, K. Beyer
Summary: Residential history is receiving increasing attention in cancer epidemiology for estimating social and physical environmental exposures and the impact of residence on cancer outcomes. Utilizing data from the SEER-Medicare database, a study found that residential mobility among older women with breast cancer in the U.S. is limited, with statistically significant differences by race/ethnicity, stage at diagnosis, and timing of the move in relation to diagnosis.
SSM-POPULATION HEALTH
(2021)
Article
Oncology
Lin Liu, Jinglan Zhu, Yun Tian
Summary: Bladder carcinosarcoma (BCS) has been found to have distinct clinicopathologic characteristics and prognosis compared to conventional bladder cancer histologies. BCS is associated with poor differentiation, advanced stage, and worse overall survival and cancer-specific survival. However, BCS is comparable to squamous cell carcinoma (SCC) in terms of survival. These findings contribute to a better understanding of BCS and have potential implications for clinical practice.
Article
Clinical Neurology
Gina Watanabe, So Yung Choi, David Cory Adamson
Summary: This study evaluated the incidence, epidemiology, and trends of pituitary adenomas (PAs) and pituitary incidentalomas (PIs) in the United States from 2004 to 2018. The results showed a significant increase in the incidence rates and proportion of PIs over the past decade. PIs were more commonly diagnosed in females and were often microadenomas compared to PAs.
WORLD NEUROSURGERY
(2022)
Article
Oncology
Kexing Xi, Hui Yu
Summary: The study compared the current N classification and a modified N2 categorization in esophageal cancer patients, finding that the N2 category should be further divided into N2a and N2b groups to provide more accurate prognosis information. This could help in developing personalized therapeutic strategies.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Jiaqin Xu, Chen Huang, Zhenyu Wu, Huilin Xu, Jiong Li, Yuntao Chen, Ce Wang, Jingjing Zhu, Guoyou Qin, Xueying Zheng, Yongfu Yu
Summary: This study aimed to characterize the clinical features of early-stage ovarian cancer survivors with second primary malignancies and provided a prediction tool for personalized risk assessment. The results showed that several factors, including age, race, histologic subtypes of OC, lymph node examination, and radiotherapy, were significantly associated with an elevated risk of developing SPMs. The proposed nomogram demonstrated clinical utility in identifying patients with different risks of SPMs.
FRONTIERS IN ONCOLOGY
(2022)
Article
Endocrinology & Metabolism
Xiaotao Dong, Kunlun Wang, Hui Yang, Ruilan Cheng, Yan Li, Yanqi Hou, Jiali Chang, Ling Yuan
Summary: A visual Nomogram was constructed to predict the overall survival (OS) of pancreatic cancer patients receiving radiotherapy (RT), based on clinical data from the SEER database and the Affiliated Cancer Hospital of Zhengzhou University. The results indicated that surgery combined with chemoradiotherapy significantly improves the OS of patients.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Endocrinology & Metabolism
Xuemei Zhang, Lele Chang, Yingying Zhu, Yuxin Mao, Tao Zhang, Qian Zhang, Chunbo Wang
Summary: This study aimed to develop nomograms for predicting the survival outcomes of individuals with advanced pleural mesothelioma (MPM) using the SEER database. Nomograms were constructed based on four variables: gender, histology, AJCC stage, and treatment. The study findings suggest that additional local radiotherapy does not significantly improve the survival of MPM patients receiving chemotherapy.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Public, Environmental & Occupational Health
L. Du, H-Y Shi, Y. Qian, X-H Jin, H-R Yu, X-L Fu, Y-P Song, H-L Chen, Y-Q Shi
Summary: The study found that cancer patients without insurance had a higher risk of suicide mortality compared to those with private insurance, while patients with Medicaid did not show significant results. Furthermore, patients in the uninsured and Medicaid groups with localized stage of disease, White ethnicity, and American Indian/Alaska Native and Asian/Pacific Islander backgrounds had a greater risk of suicide mortality than insured patients.
Article
Oncology
Qiang Wang, Junbin Zhong, Qing Huang, Zhuanpeng Chen, Jianchang Wei, Fang Wei, Jie Cao
Summary: MPA is a rare histological subtype of gastric cancer with similar prognosis to CA patients. Surgery and chemotherapy are effective treatments for MPA patients.
Article
Oncology
Claudia Colla Ruvolo, Lara Franziska Stolzenbach, Luigi Nocera, Marina Deuker, Francesco A. Mistretta, Stefano Luzzago, Zhe Tian, Nicola Longo, Markus Graefen, Felix K. H. Chun, Fred Saad, Alberto Briganti, Ottavio De Cobelli, Vincenzo Mirone, Pierre I. Karakiewicz
Summary: The study revealed that low-risk Mexican-American prostate cancer patients do not differ significantly from low-risk Caucasian patients, but favorable intermediate-risk Mexican-American patients have higher rates of upgrading compared to their Caucasian counterparts. These differences should be taken into consideration in treatment decision-making.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
(2021)
Article
Biochemistry & Molecular Biology
Tessa R. Lavorgna, Mohammad Hussein, Peter P. Issa, Eman Toraih, Emad Kandil
Summary: This study investigated the trends in thyroid cancer incidence and survival, focusing on patient race and UV exposure. The findings suggest that UV exposure is negatively correlated with thyroid cancer incidence and may serve as a protective factor in its development. However, despite this correlation, black men have the worst 5-year survival rate compared to other ethnic populations.
Article
Oncology
Changchuan Jiang, Lei Deng, Matthew A. Karr, Yumeng Wen, Qian Wang, Stuthi Perimbeti, Charles L. Shapiro, Xuesong Han
Summary: The study revealed an increasing trend in the prevalence of chronic diseases among adult cancer survivors in the United States, with a substantial increase in the number of survivors with comorbid illnesses over the past 2 decades. Additionally, the prevalence of MCC was more pronounced among survivors aged 18 to 44 years.
Article
Oncology
Janet S. de Moor, Emily C. Dowling, Donatus U. Ekwueme, Gery P. Guy, Juan Rodriguez, Katherine S. Virgo, Xuesong Han, Erin E. Kent, Chunyu Li, Kristen Litzelman, Timothy S. McNeel, Benmei Liu, K. Robin Yabroff
JOURNAL OF CANCER SURVIVORSHIP
(2017)
Correction
Oncology
Katherine S. Virgo, Ethan Basch, D. Andrew Loblaw, Thomas K. Oliver, R. Bryan Rumble, Michael A. Carducci
JOURNAL OF CLINICAL ONCOLOGY
(2017)
Article
Oncology
Matthew P. Banegas, John F. Dickerson, Erin E. Kent, Janet S. de Moor, Katherine S. Virgo, Gery P. Guy, Donatus U. Ekwueme, Zhiyuan Zheng, Stephanie Nutt, Loyce Pace, Alexandra Varga, Lisa Waiwaiole, Jennifer Schneider, K. Robin Yabroff
JOURNAL OF CANCER SURVIVORSHIP
(2018)
Meeting Abstract
Oncology
Amy J. Davidoff, Xuesong Han, K. Robin Yabroff, Xin Hu, Zhiyuan Zheng, Katherine S. Virgo
JOURNAL OF CLINICAL ONCOLOGY
(2018)
Article
Oncology
Matthew P. Banegas, Jennifer L. Schneider, Alison J. Firemark, John F. Dickerson, Erin E. Kent, Janet S. de Moor, Katherine S. Virgo, Gery P. Guy, Donatus U. Ekwueme, Zhiyuan Zheng, Alexandra M. Varga, Lisa A. Waiwaiole, Stephanie M. Nutt, Aditi Narayan, K. Robin Yabroff
JOURNAL OF CANCER SURVIVORSHIP
(2019)
Editorial Material
Health Care Sciences & Services
Julie M. Zito, Katherine S. Virgo, Linda D. Green
Article
Oncology
Xuesong Han, Jingxuan Zhao, Zhiyuan Zheng, Janet S. de Moor, Katherine S. Virgo, K. Robin Yabroff
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
(2020)
Editorial Material
Health Care Sciences & Services
Julie M. Zito, Katherine S. Virgo, Linda D. Green
Article
Oncology
Janet S. de Moor, Erin E. Kent, Timothy S. McNeel, Katherine S. Virgo, Jennifer Swanberg, J. Kathleen Tracy, Matthew P. Banegas, Xuesong Han, Jin Qin, K. Robin Yabroff
Summary: The national prevalence of employment changes after a cancer diagnosis has not been fully documented. More than 3.5 million adult cancer survivors in the United States made employment changes, with the majority opting for extended paid time off. Younger, female, non-White, or multiple races and ethnicities survivors were more likely to make employment changes.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
(2021)
Editorial Material
Health Care Sciences & Services
Katherine S. Virgo, Julie M. Zito, Linda D. Green
Article
Oncology
Katherine S. Virgo, R. Bryan Rumble, Ronald de Wit, David S. Mendelson, Thomas J. Smith, Mary-Ellen Taplin, James L. Wade, Charles L. Bennett, Howard I. Scher, Paul L. Nguyen, Martin Gleave, Scott C. Morgan, Andrew Loblaw, Sean Sachdev, David L. Graham, Neha Vapiwala, Amy M. Sion, Virgil H. Simons, James Talcott
Summary: The updated ASCO guidelines recommend using Docetaxel, abiraterone, enzalutamide, or apalutamide in combination with androgen deprivation therapy (ADT) as standard care for noncastrate metastatic prostate cancer. In locally advanced nonmetastatic prostate cancer patients who have undergone radiotherapy, ADT combined with abiraterone and prednisolone is suggested. The guidelines also provide recommendations for management of biochemically recurrent nonmetastatic prostate cancer.
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Letter
Oncology
James A. Talcott, Katherine S. Virgo
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Article
Oncology
Katherine S. Virgo, R. Bryan Rumble, James Talcott
JOURNAL OF CLINICAL ONCOLOGY
(2023)
Article
Psychology, Social
Erin E. Kent, Amy Davidoff, Janet S. de Moor, Timothy S. McNeel, Katherine S. Virgo, Diarmuid Coughlan, Xuesong Han, Donatus U. Ekwueme, Gery P. Guy, Matthew P. Banegas, Catherine M. Alfano, Emily C. Dowling, K. Robin Yabroff
JOURNAL OF PSYCHOSOCIAL ONCOLOGY
(2018)
Meeting Abstract
Psychology, Multidisciplinary
Matthew Banegas, Alexandra Varga, Jennifer Schneider, John Dickerson, Erin Kent, Janet DeMoor, Katherine Virgo, Gery Guy, Zhiyuan Zheng, Stephanie Nutt, Lloyce Pace, Lisa Waiwaiole, Donatus Ekwueme
ANNALS OF BEHAVIORAL MEDICINE
(2017)